Active pharmaceutical ingredient–incorporated supramolecular materials as antibacterial agents
Chemical Communications · 2026 · 62 (50) · 12587-12591
DOI: 10.1039/d6cc02299e ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2026. Verfasst von Sreejith Sudhakaran Jayabhavan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Science Institute, University of Iceland, 107, Iceland. krishna@hi.is. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Metronidazole. Die Arbeit nennt 65 Literaturangaben. Gefördert von: Rannís, Háskóli Íslands.
Abstract (Originalsprache)
Active pharmaceutical ingredient (API)-incorporated supramolecular materials that are non-toxic to mammalian fibroblast cells display significant activity against an anaerobic bacterium ( P. gingivalis ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Science Institute, University of Iceland, 107, Iceland. krishna@hi.is.
- Polymeric Biomaterials Lab, School of Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi 682041, India.
Förderung
- Rannís
- Háskóli Íslands
Zitieren
APA
Jayabhavan, S. S., Chandramouli, A., Rangasamy, J., & Damodaran, K. K. (2026). Active pharmaceutical ingredient–incorporated supramolecular materials as antibacterial agents. Chemical Communications, 62(50), 12587-12591. https://doi.org/10.1039/d6cc02299e
Vancouver
Jayabhavan SS, Chandramouli A, Rangasamy J, Damodaran KK. Active pharmaceutical ingredient–incorporated supramolecular materials as antibacterial agents. Chemical Communications. 2026;62(50):12587-12591. doi:10.1039/d6cc02299e
BibTeX
@article{Jayabhavan2026,
author = {Jayabhavan, Sreejith Sudhakaran and Chandramouli, Arthi and Rangasamy, Jayakumar and Damodaran, Krishna K},
title = {Active pharmaceutical ingredient–incorporated supramolecular materials as antibacterial agents},
journal = {Chemical Communications},
year = {2026},
volume = {62},
number = {50},
pages = {12587--12591},
doi = {10.1039/d6cc02299e}
}
EUVIMED